Julius A Carillo studies the impact of treating heart conditions, specifically severe mitral regurgitation (a condition where the heart's mitral valve doesn’t close tightly, causing blood to flow backward) during surgeries where mechanical heart pumps (LVADs) are inserted for patients experiencing severe heart failure. His research compares outcomes of patients who had their mitral valve repaired at the same time as receiving a heart pump to those who underwent pump surgery alone, aiming to find ways to improve survival rates and reduce hospital visits due to heart issues.
Key findings
In a study of 21 patients who received mitral valve repair alongside LVAD insertion, there was an observed improvement in survival rates compared to 57 patients who did not receive the repair.
Patients in the mitral valve repair group experienced fewer heart-related hospitalizations than those who only had the heart pump inserted.
While the differences in this particular study weren't statistically significant, the trends suggest a potential benefit of simultaneous mitral valve repair and LVAD insertion.
Frequently asked questions
Does Dr. Carillo study heart valve repair?
Yes, Dr. Carillo specifically examines the effects of repairing leaky mitral valves during heart pump surgeries.
What heart conditions has Dr. Carillo researched?
He primarily researches severe mitral regurgitation and its treatment options during mechanical heart pump surgeries.
Is Dr. Carillo's work relevant to heart failure patients?
Yes, his research is crucial for patients with severe heart failure who may also have issues with their mitral valve.
Publications in plain English
Ability of a Polyphenol-Rich Nutraceutical to Reduce Central Nervous System Lipid Peroxidation by Analysis of Oxylipins in Urine: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
2023
Antioxidants (Basel, Switzerland)
Arcusa R, Carillo JÁ, Cerdá B, Durand T, Gil-Izquierdo Á +4 more
Plain English This study looked at whether a supplement rich in polyphenols, found in fruits and vegetables, can lower lipid peroxidation levels in the central nervous system. Researchers found that after taking a 600 mg supplement for 16 weeks, participants showed significant decreases in certain harmful compounds in their urine, specifically three metabolites from adrenic acid and one from docosahexaenoic acid, with reductions all showing strong statistical significance (p < 0.001 or p < 0.015). This matters because it indicates that such a nutraceutical could help protect the brain from oxidative damage.
Who this helps: This helps patients looking for dietary ways to support brain health.
Early experience with donation after circulatory death heart transplantation using normothermic regional perfusion in the United States.
2022
The Journal of thoracic and cardiovascular surgery
Smith DE, Kon ZN, Carillo JA, Chen S, Gidea CG +5 more
Plain English This study looked at a new method for transplanting hearts from donors whose hearts had stopped beating (called donation after circulatory death, or DCD). Researchers performed 8 heart transplants using this method and found that all donor hearts were successfully revived and functioned well without extra support after surgery. Importantly, the survival rate was 100% after about 10 months of follow-up, showing that this approach can significantly increase the number of available donor hearts.
Who this helps: This helps patients needing heart transplants, as it increases the number of donor hearts available.
One-Year Outcomes With Venovenous Extracorporeal Membrane Oxygenation Support for Severe COVID-19.
2022
The Annals of thoracic surgery
Smith DE, Chang SH, Geraci TC, James L, Kon ZN +8 more
Plain English This study looked at patients with severe COVID-19 who received advanced life support called venovenous extracorporeal membrane oxygenation (VV-ECMO) when they could no longer breathe on their own. Out of 30 patients treated, 27 (90%) survived long enough to leave the hospital, and after an average of about 11 months, 86.7% were still alive. Most survivors had good lung function and could walk a decent distance, indicating they were recovering well.
Who this helps: This helps patients who suffer from severe COVID-19 and may need advanced respiratory support.
Efficacy of proning in acute respiratory distress syndrome on extracorporeal membrane oxygenation.
2022
JTCVS techniques
Chang SH, Smith DE, Carillo JA, Sommer PM, Geraci TC +7 more
Plain English This study looked at how turning patients with severe lung issues (called ARDS) onto their stomachs (proning) affects those on a life-support machine known as ECMO. Out of 30 patients studied, 12 were turned onto their stomachs, and this led to better lung function in 84% of cases and improved oxygen levels in 76%, with no serious complications. These findings are important because they show that proning is safe and can help patients recover better while using ECMO.
Who this helps: This benefits patients suffering from severe respiratory distress and their doctors.
Extracorporeal Membrane Oxygenation Support in Severe COVID-19.
2021
The Annals of thoracic surgery
Kon ZN, Smith DE, Chang SH, Goldenberg RM, Angel LF +6 more
Plain English This study looked at how effective extracorporeal membrane oxygenation (ECMO) treatment is for patients with severe COVID-19 who need help breathing. Out of 321 patients treated, 77 were considered for ECMO, and 27 actually received it. Remarkably, 96.3% of these patients survived, with only one death reported, indicating that ECMO can be a valuable treatment for critically ill COVID-19 patients.
Who this helps: This benefits patients with severe COVID-19 and their doctors by providing a potential life-saving treatment option.
Comparison of device-specific adverse event profiles between Impella platforms.
2020
Journal of cardiac surgery
Chen S, Paone D, Spellman L, Ranganath NK, Carillo JA +7 more
Plain English This study looked at two types of Impella heart support devices used for patients with severe heart issues. Researchers analyzed 91 patients and found that those using the Impella 5.0/LD had fewer complications, including less blood breakdown and a lower need for additional support compared to those with the Impella CP. Importantly, the 5.0/LD also helped more patients survive their hospital stay.
Who this helps: This research benefits patients who are critically ill and require heart support during treatment.
Impact of concomitant mitral valve repair for severe mitral regurgitation at the time of continuous-flow left ventricular assist device insertion.
2017
Interactive cardiovascular and thoracic surgery
Sandoval E, Singh SK, Carillo JA, Baldwin ACW, Ono M +3 more
Plain English Doctors implant mechanical heart pumps (LVADs) in patients with severe heart failure, and many of these patients also have a leaky mitral valve. This study compared 21 patients who had their mitral valve repaired during the pump surgery with 57 patients who didn't get the repair, and found that the repair group showed better survival rates and fewer heart-related hospitalizations afterward.
Although the difference wasn't statistically proven in the numbers, the trend strongly suggests that fixing the leaky valve at the same time as installing the heart pump helps patients live longer and stay healthier—so doctors should do larger studies to confirm whether this combined approach is actually worth doing.
Deane E Smith Zachary N Kon Nader Moazami Stephanie H Chang Travis C Geraci Aubrey C Galloway David Williams Darien Paone Robert J Cerfolio Stacey Chen
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.